McKesson to Take Option Care Private in 5.8B Deal
Drug distributor McKesson and private equity firm Clayton Dubilier and Rice agreed to take infusion therapy provider Option Care Health private in a 5.8 billion dollar transaction. The deal expands McKessons healthcare footprint amid rising demand for home based care.
Xurve View
Insights:
Xurve View
MCKESSON CORP and Clayton Dubilier & Rice agreed on Tuesday afternoon to take OPTION CARE HEALTH INC private in a deal valued at $5.8 billion. The transaction offers $32.05 per share, representing a 37.1% premium to the target's previous close. The buyout expands the distributor's healthcare services footprint into home infusion care.
